PhenomeX Inc. Common Stock
CELL
CELL was delisted on the 29th of September, 2023.
137 hedge funds and large institutions have $954M invested in PhenomeX Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 62 increasing their positions, 23 reducing their positions, and 48 closing their positions.
170% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 23
30% more call options, than puts
Call options by funds: $8.76M | Put options by funds: $6.75M
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
12% less funds holding
Funds holding: 156 → 137 (-19)
38% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 48
49% less capital invested
Capital invested by funds: $1.87B → $954M (-$920M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$65.7M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$60.8M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$49.7M |
| 4 |
Two Sigma Advisers
New York
|
+$38.3M |
| 5 |
Swedbank
Stockholm,
Sweden
|
+$38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
-$137M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$53.6M |
| 3 |
SUT
SC US (TTGP)
Menlo Park,
California
|
-$44.4M |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$30.4M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$17M |
CELL Hedge Fund Activity: Q3 2021 in Review
137 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in PhenomeX Inc. Common Stock (CELL) for Q3 2021, worth a combined $954M — down 49% from $1.87B a quarter earlier.
Sellers outnumbered buyers: 48 funds closed out of CELL and 30 opened new positions — a net loss of 18 holders — while 23 trimmed existing stakes and 62 added.
The largest buyer was Mackenzie Financial, adding an estimated $65.7M. The largest seller was Fred Alger Management, exiting entirely with an estimated $137M sold.
- 137 institutional investors held PhenomeX Inc. Common Stock (CELL) as of Q3 2021, down from 156 in Q2 2021.
- Funds reported $954M of PhenomeX Inc. Common Stock stock for Q3 2021, down 49% quarter-over-quarter.
- 30 funds opened new PhenomeX Inc. Common Stock positions in Q3 2021 and 48 closed out, a net change of -18 holders.
- The largest PhenomeX Inc. Common Stock buyer in Q3 2021 was Mackenzie Financial, an estimated $65.7M added.
- The largest PhenomeX Inc. Common Stock seller in Q3 2021 was Fred Alger Management, an estimated $137M sold.
Based on aggregated 13F filings for Q3 2021.